Subscribe To
Diamedica therapeutics to present at the oppenheimer 33rd annual healthcare conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel ...
March 13, 2023, 8:00 am
Catalent, inc. to present at march investor conferences
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better ...
March 9, 2023, 4:31 pm
Azitra starts $17 million u.s. ipo effort
Azitra has filed to raise approximately $17 million in a U.S. IPO. The firm is an early-stage biopharma developing drug ...
March 8, 2023, 2:11 pm
Weightwatchers ceo: ‘we have re-embraced our core expertise'
WeightWatchers CEO Sima Sistani joins Yahoo Finance Live to discuss company earnings, targeting lifestyle and behavior changes, drug ...
March 8, 2023, 11:45 am
Roquefort develops a fifth programme using a technology pioneer by moderna and biontech
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) said has developed a new platform of potential anti-cancer messenger RNA (mRNA) therapeutics, expand...
March 8, 2023, 2:34 am
Spero therapeutics to provide business update and report fourth quarter and full year 2022 financial results on monday, march 13, 2023
CAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
March 6, 2023, 8:05 am
Keros therapeutics reports recent business highlights and fourth quarter and full year 2022 financial results
LEXINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage bio...
March 3, 2023, 9:01 pm
Praxis: shaking the dust off calcium channel blockers for essential tremor
Praxis Precision Medicines' ulixacaltamide (PRAX-944) is a potent and selective small molecule T-type Ca2+ channel blocker being developed for the pot...
March 3, 2023, 2:26 am
Wave life sciences to webcast conference call of fourth quarter and full year 2022 financial results on march 22, 2023
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to d...
March 2, 2023, 1:30 pm
Braxia scientific reports 50.5% increase in 3q revenue; updates on acquisition by irwin naturals
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has reported third-quarter results that show a sharp rise in revenue as the company increased its in-cl...
March 2, 2023, 6:46 am
Bonsai tattoo removal offers superior laser tattoo removal and fading for cover-ups in rowlett, tx featuring the astanza duality
ROWLETT, Texas, March 01, 2023 (GLOBE NEWSWIRE) — Bonsai Tattoo Removal is a rising laser tattoo removal practice in Rowlett, Texas that specializes...
March 1, 2023, 1:18 pm
Fda approves reata's rare nervous-system drug amid questions about changing regulatory environment for neuroscience treatments
The U.S. Food and Drug Administration on Tuesday approved Reata Pharmaceuticals Inc.'s treatment for Friedreich's ataxia, a rare inherited disease tha...
February 28, 2023, 5:35 pm
Pfizer in talks to buy seagen for $30 billion or more
The deal would strengthen Pfizer's lineup of cancer treatments, The Wall Street Journal reports....
February 27, 2023, 4:17 am
Calliditas: underfollowed swedish biotech focusing on rare kidney disease
Calliditas Therapeutics is a commercial-stage biopharmaceutical company based in Sweden focused on developing and commercializing novel ...
February 27, 2023, 1:41 am
Sellas life sciences raises $20 million from public offering of stock, warrants
Sellas Life Sciences Group Inc. SLS, -3.40% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy sto...
February 24, 2023, 8:42 am
Nektar stock drops more than 30% after study involving lupus treatment will not go forward
Shares of Nektar Therapeutics NKTR, -1.66% plunged more than 30% in the extended session Thursday after the biopharma company reported that a study di...
February 23, 2023, 5:24 pm
Genprex unveils groundbreaking data from primate study on its novel gene therapy to treat type 1 diabetes at attd 2023 in berlin
Genprex, Inc. (NASDAQ:GNPX) has announced that data highlighting the potential of its gene therapy for Type 1 diabetes is being presented by its resea...
February 23, 2023, 8:40 am
Medivir to present at the erik penser bank healthcare day
STOCKHOLM , Feb. 23, 2023 /PRNewswire/ -- Medivir AB (Stockholm: MVIR), a pharmaceutical company focused on developing innovative ...
February 23, 2023, 3:03 am
Artelo biosciences to present at microcap rodeo's annual winter wonderland – best ideas virtual investor conference on february 22, 2023
SOLANA BEACH, CA / ACCESSWIRE / February 15, 2023 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulat...
February 15, 2023, 8:30 am
Disc medicine announces $62.5 million financing led by bain capital life sciences to advance portfolio of novel hematology programs
WATERTOWN, Mass., Feb. 14, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) a clinical-stage biopharmaceutical company focused on the disc...
February 14, 2023, 11:30 am